Author Correction: Cancer-associated Histone H3 N-terminal arginine mutations disrupt PRC2 activity and impair differentiation

Affiliations

• ¹ Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA. ben46@pitt.edu.
• ² Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA. ben46@pitt.edu.
• ³ UPMC Hillman Cancer Center, Pittsburgh, PA, 15213, USA. ben46@pitt.edu.
• ⁴ Laboratory of Chromatin Biology and Epigenetics, The Rockefeller University, New York, NY, 10065, USA.
• ⁵ Bioinformatics Resource Center, The Rockefeller University, New York, NY, 10065, USA.
• ⁶ Department of Chemistry, Princeton University, Princeton, NJ, 08544, USA.
• ⁷ Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
• ⁸ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
• ⁹ Department of Neuroscience, Developmental and Regenerative Biology, The University of Texas at San Antonio, San Antonio, TX, 78249, USA.
• ¹⁰ Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
• ¹¹ Laboratory of Comparative Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
• ¹² Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.
• ¹³ UPMC Hillman Cancer Center, Pittsburgh, PA, 15213, USA.
• ¹⁴ Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO, 63110, USA.